ALNY logo

Alnylam Pharmaceuticals (ALNY) return on equity

annual ROE:

-414.62%-614.15%(-307.80%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ALNY annual return on equity is -414.62%, with the most recent change of -614.15% (-307.80%) on December 31, 2024.
  • During the last 3 years, ALNY annual ROE has fallen by -308.31% (-290.01%).
  • ALNY annual ROE is now -307.80% below its all-time high of 199.53%, reached on December 31, 2023.

Performance

ALNY ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYprofitability metrics

quarterly ROE:

-509.33%-1414.66%(-156.26%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ALNY quarterly return on equity is -509.33%, with the most recent change of -1414.66% (-156.26%) on March 31, 2025.
  • Over the past year, ALNY quarterly ROE has dropped by -640.34% (-488.77%).
  • ALNY quarterly ROE is now -156.26% below its all-time high of 905.33%, reached on December 31, 2024.

Performance

ALNY quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

ALNY ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-307.8%-488.8%
3 y3 years-290.0%-302.1%
5 y5 years-541.2%-784.9%

ALNY ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-307.8%+21.2%-156.3%+91.2%
5 y5-year-307.8%+21.2%-156.3%+91.2%
alltimeall time-307.8%+21.2%-156.3%+91.2%

ALNY ROE History

DateAnnualQuarterly
Mar 2025
-
-509.33%(-156.3%)
Dec 2024
-414.62%(-307.8%)
905.33%(+179.7%)
Sep 2024
-
323.66%(+575.4%)
Jun 2024
-
47.92%(-63.4%)
Mar 2024
-
131.01%(-21.6%)
Dec 2023
199.53%(-137.9%)
167.09%(-18.8%)
Sep 2023
-
205.70%(-56.8%)
Jun 2023
-
476.27%(-108.2%)
Mar 2023
-
-5780.99%(+860.3%)
Dec 2022
-526.14%(+394.9%)
-601.97%(+88.8%)
Sep 2022
-
-318.86%(+80.4%)
Jun 2022
-
-176.73%(+39.5%)
Mar 2022
-
-126.66%(+23.0%)
Dec 2021
-106.31%(+52.0%)
-103.00%(+17.2%)
Sep 2021
-
-87.89%(+7.3%)
Jun 2021
-
-81.94%(+10.5%)
Mar 2021
-
-74.18%(+11.0%)
Dec 2020
-69.92%(+8.1%)
-66.85%(+5.2%)
Sep 2020
-
-63.54%(+13.4%)
Jun 2020
-
-56.02%(-2.7%)
Mar 2020
-
-57.56%(-0.6%)
Dec 2019
-64.66%(+30.3%)
-57.90%(+8.4%)
Sep 2019
-
-53.40%(-4.1%)
Jun 2019
-
-55.69%(+7.0%)
Mar 2019
-
-52.07%(+8.3%)
Dec 2018
-49.63%(+35.8%)
-48.06%(+6.6%)
Sep 2018
-
-45.08%(+15.9%)
Jun 2018
-
-38.91%(-3.1%)
Mar 2018
-
-40.16%(-6.7%)
Dec 2017
-36.54%(-2.7%)
-43.06%(-7.7%)
Sep 2017
-
-46.64%(+5.1%)
Jun 2017
-
-44.38%(+8.2%)
Mar 2017
-
-41.00%(+9.7%)
Dec 2016
-37.54%(+42.4%)
-37.37%(+13.5%)
Sep 2016
-
-32.93%(+14.7%)
Jun 2016
-
-28.70%(+12.0%)
Mar 2016
-
-25.62%(+13.6%)
Dec 2015
-26.36%(-55.9%)
-22.56%(+24.0%)
Sep 2015
-
-18.19%(+10.1%)
Jun 2015
-
-16.52%(+7.9%)
Mar 2015
-
-15.31%(-65.9%)
Dec 2014
-59.74%
-44.96%(-18.4%)
Sep 2014
-
-55.10%(-14.4%)
DateAnnualQuarterly
Jun 2014
-
-64.37%(-16.7%)
Mar 2014
-
-77.28%(+129.0%)
Dec 2013
-44.13%(-47.5%)
-33.75%(-30.3%)
Sep 2013
-
-48.45%(-0.4%)
Jun 2013
-
-48.64%(-5.4%)
Mar 2013
-
-51.40%(-21.0%)
Dec 2012
-84.12%(+101.5%)
-65.05%(+81.0%)
Sep 2012
-
-35.94%(+6.5%)
Jun 2012
-
-33.76%(-7.1%)
Mar 2012
-
-36.35%(-13.5%)
Dec 2011
-41.74%(+61.2%)
-42.00%(+21.8%)
Sep 2011
-
-34.49%(+13.3%)
Jun 2011
-
-30.44%(+2.8%)
Mar 2011
-
-29.61%(+13.5%)
Dec 2010
-25.89%(+3.4%)
-26.08%(+0.9%)
Sep 2010
-
-25.86%(+3.8%)
Jun 2010
-
-24.92%(-12.3%)
Mar 2010
-
-28.43%(+13.0%)
Dec 2009
-25.04%(+91.4%)
-25.17%(-0.6%)
Sep 2009
-
-25.31%(+16.9%)
Jun 2009
-
-21.66%(+32.6%)
Mar 2009
-
-16.33%(+25.4%)
Dec 2008
-13.08%(-69.4%)
-13.02%(+71.1%)
Sep 2008
-
-7.61%(-77.3%)
Jun 2008
-
-33.46%(-0.8%)
Mar 2008
-
-33.74%(-24.0%)
Dec 2007
-42.70%(+62.2%)
-44.39%(-19.3%)
Sep 2007
-
-55.04%(+72.3%)
Jun 2007
-
-31.94%(-2.4%)
Mar 2007
-
-32.73%(+12.7%)
Dec 2006
-26.32%(-66.9%)
-29.05%(-40.3%)
Sep 2006
-
-48.68%(-24.2%)
Jun 2006
-
-64.19%(-22.7%)
Mar 2006
-
-83.05%(-22.5%)
Dec 2005
-79.53%(-76.3%)
-107.17%(+15.2%)
Sep 2005
-
-93.02%(+31.5%)
Jun 2005
-
-70.76%(-21.4%)
Mar 2005
-
-90.05%(-58.1%)
Dec 2004
-336.03%(-458.5%)
-214.80%(-51.7%)
Sep 2004
-
-444.77%(-167.8%)
Jun 2004
-
656.18%(+635.6%)
Mar 2004
-
89.20%(+33.0%)
Dec 2003
93.73%(+5.3%)
67.06%
Dec 2002
89.02%
-

FAQ

  • What is Alnylam Pharmaceuticals annual return on equity?
  • What is the all time high annual ROE for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals annual ROE year-on-year change?
  • What is Alnylam Pharmaceuticals quarterly return on equity?
  • What is the all time high quarterly ROE for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals quarterly ROE year-on-year change?

What is Alnylam Pharmaceuticals annual return on equity?

The current annual ROE of ALNY is -414.62%

What is the all time high annual ROE for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high annual return on equity is 199.53%

What is Alnylam Pharmaceuticals annual ROE year-on-year change?

Over the past year, ALNY annual return on equity has changed by -614.15% (-307.80%)

What is Alnylam Pharmaceuticals quarterly return on equity?

The current quarterly ROE of ALNY is -509.33%

What is the all time high quarterly ROE for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high quarterly return on equity is 905.33%

What is Alnylam Pharmaceuticals quarterly ROE year-on-year change?

Over the past year, ALNY quarterly return on equity has changed by -640.34% (-488.77%)
On this page